X-37, LLC, an artificial intelligence-enabled drug discovery company, announced today that it has closed a $14.5 million Series A financing. The funding round was led by DCVC Bio and was joined by Alpha Intelligence Capital and Hemi Ventures. The Series A funding will be used to expand the number of drug development programs at X-37 and to advance identified drug leads through … [Read more...] about X-37 Announces $14.5 Million Series A
drug discovery
SGI-DNA Secures $25 Million Series A Financing to Support Commercial Launch
Company using capital for the global commercial launch of the BioXp™ 3200 System—a fully automated gene synthesis and cloning platform powered by Gibson Assembly® Technology—and execution of its product roadmap for automated printing of biological materials and DNA data storage SGI-DNA, a company dedicated to developing transformative synthetic genomics technologies and … [Read more...] about SGI-DNA Secures $25 Million Series A Financing to Support Commercial Launch